Table I.
Clinical characteristics of 12 BCa patients.
Number | Sex | Age (years) | Tumor type | Histopathology | |
---|---|---|---|---|---|
Stage | Grade | ||||
01 | Male | 55 | MIUC | T2 | High |
02 | Male | 56 | MIUC | T2 | High |
03 | Male | 59 | MIUC | T2 | High |
04 | Female | 82 | MIUC | T1 | High |
05 | Male | 67 | MIUC | T2 | High |
06 | Male | 76 | MIUC | T2b | Squamous metaplasia |
07 | Male | 76 | MIUC | T2 | High |
08 | Female | 60 | MIUC | T2 | High |
09 | Male | 67 | NMIUC | Ta | High |
10 | Male | 58 | NMIUC | Ta | High |
11 | Male | 85 | MIUC | T2a | High |
12 | Female | 61 | MIUC | T2 | Squamous metaplasia |
MIUC, muscle-invasive urothelial carcinoma; NMIUC, non-muscle-invasive urothelial carcinoma. BCa, bladder cancer.